Sunshine Biopharma Future Growth
Future criteria checks 5/6
Sunshine Biopharma is forecast to grow earnings and revenue by 134.4% and 67.5% per annum respectively while EPS is expected to grow by 138.2% per annum.
Key information
134.4%
Earnings growth rate
138.2%
EPS growth rate
| Biotechs earnings growth | 21.1% |
| Revenue growth rate | 67.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 09 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Sunshine Biopharma, Inc.'s (NASDAQ:SBFM) 73% Dip In Price Shows Sentiment Is Matching Revenues
Mar 14
Sunshine Biopharma, Inc.'s (NASDAQ:SBFM) Share Price Is Matching Sentiment Around Its Revenues
Jan 29Slammed 26% Sunshine Biopharma, Inc. (NASDAQ:SBFM) Screens Well Here But There Might Be A Catch
Sep 12Sunshine Biopharma acquires Nora Pharma for C$30M
Oct 20We Think Sunshine Biopharma (NASDAQ:SBFM) Can Afford To Drive Business Growth
Aug 08Sunshine Biopharma reports 1H results
Aug 04Sunshine Biopharma: Advancing Novel Cancer Therapies And Antiviral Drugs
Apr 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 100 | 17 | N/A | N/A | 1 |
| 12/31/2024 | 44 | 2 | N/A | N/A | 1 |
| 12/31/2023 | 24 | -5 | -10 | -9 | N/A |
| 9/30/2023 | 20 | -27 | -9 | -8 | N/A |
| 6/30/2023 | 15 | -28 | -10 | -9 | N/A |
| 3/31/2023 | 9 | -27 | -6 | -6 | N/A |
| 12/31/2022 | 4 | -27 | -6 | -5 | N/A |
| 9/30/2022 | 0 | -3 | -3 | -3 | N/A |
| 6/30/2022 | 0 | -5 | -3 | -3 | N/A |
| 3/31/2022 | 0 | -7 | -3 | -3 | N/A |
| 12/31/2021 | 0 | -12 | -2 | -2 | N/A |
| 9/30/2021 | 0 | -14 | -2 | -2 | N/A |
| 6/30/2021 | 0 | -11 | -1 | -1 | N/A |
| 3/31/2021 | 0 | -9 | -1 | -1 | N/A |
| 12/31/2020 | 0 | -3 | -1 | -1 | N/A |
| 9/30/2020 | 0 | -2 | 0 | 0 | N/A |
| 6/30/2020 | 0 | -2 | 0 | 0 | N/A |
| 3/31/2020 | 0 | -1 | 0 | 0 | N/A |
| 12/31/2019 | 0 | -1 | 0 | 0 | N/A |
| 9/30/2019 | 0 | -1 | 0 | 0 | N/A |
| 6/30/2019 | 0 | -2 | -1 | -1 | N/A |
| 3/31/2019 | 0 | -2 | -1 | -1 | N/A |
| 12/31/2018 | N/A | -2 | -1 | -1 | N/A |
| 9/30/2018 | N/A | -2 | -1 | -1 | N/A |
| 6/30/2018 | N/A | -1 | -1 | -1 | N/A |
| 3/31/2018 | 0 | -1 | -1 | -1 | N/A |
| 12/31/2017 | N/A | -1 | -1 | -1 | N/A |
| 9/30/2017 | N/A | -2 | N/A | 0 | N/A |
| 6/30/2017 | N/A | -3 | N/A | 0 | N/A |
| 3/31/2017 | N/A | -3 | N/A | 0 | N/A |
| 12/31/2016 | N/A | -3 | N/A | 0 | N/A |
| 9/30/2016 | N/A | -3 | N/A | -1 | N/A |
| 6/30/2016 | N/A | -2 | N/A | -1 | N/A |
| 3/31/2016 | 0 | -2 | N/A | -1 | N/A |
| 12/31/2015 | 0 | -2 | N/A | -1 | N/A |
| 9/30/2015 | 0 | -1 | N/A | -1 | N/A |
| 6/30/2015 | 0 | -1 | N/A | -1 | N/A |
| 3/31/2015 | N/A | -2 | N/A | -1 | N/A |
| 12/31/2014 | N/A | -2 | N/A | -1 | N/A |
| 9/30/2014 | N/A | -2 | N/A | 0 | N/A |
| 6/30/2014 | N/A | -2 | N/A | 0 | N/A |
| 3/31/2014 | N/A | -2 | N/A | 0 | N/A |
| 12/31/2013 | N/A | -2 | N/A | -1 | N/A |
| 9/30/2013 | N/A | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SBFM is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: SBFM is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SBFM is expected to become profitable in the next 3 years.
Revenue vs Market: SBFM's revenue (67.5% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: SBFM's revenue (67.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SBFM's Return on Equity is forecast to be high in 3 years time